JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Hsa_Circ_0002762 may be a New Marker for the Gastric Cancer Diagnosis and Prognosis

Clinical Laboratory +

|

May 15, 2024

|

May 15, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Gastric carcinoma (GC) is a significant health concern. Hsa_circ_0002762 shows elevated expression in GC and can serve as a novel diagnostic and prognostic biomarker.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background

  • Gastric carcinoma (GC) presents a high global incidence and mortality rate.
  • Early-stage GC often lacks distinct symptoms, complicating diagnosis.
  • Hsa_circ_0002762, previously linked to cervical cancer, is investigated for its role in GC.

Purpose Of The Study

  • To investigate the expression and clinical significance of hsa_circ_0002762 in gastric cancer.
  • To evaluate hsa_circ_0002762 as a potential diagnostic biomarker for GC.
  • To assess the prognostic value of hsa_circ_0002762 in GC patients.

Main Methods

  • Quantitative real-time polymerase chain reaction (qPCR) to measure hsa_circ_0002762 expression.
  • Analysis of tissue samples from 28 GC cases and adjacent tissues.
  • Assessment of plasma samples from healthy individuals, benign gastritis patients, and GC patients using ROC curve analysis.
  • Kaplan-Meier survival analysis for prognostic evaluation in 36 GC cases.

Main Results

  • Hsa_circ_0002762 expression was significantly upregulated in GC tissues and plasma.
  • Serum hsa_circ_0002762 demonstrated superior diagnostic efficiency (AUC=0.784) compared to CEA and CA199.
  • Combined biomarker analysis enhanced diagnostic sensitivity.
  • Postoperative monitoring of serum hsa_circ_0002762 showed utility in predicting clinical prognosis.

Conclusions

  • Hsa_circ_0002762 is a promising novel biomarker for GC diagnosis.
  • Serum hsa_circ_0002762 can be utilized as a prognostic indicator for gastric cancer.
  • Further research is warranted to explore the therapeutic potential of hsa_circ_0002762.